Form 4: Adverum Biotechnologies Director Increases Stake in Company

Director Braden Michael Leonard reports purchasing additional shares of Adverum Biotechnologies, Inc. on March 26th and 27th, 2025.

Summary

• Braden Michael Leonard, a director of Adverum Biotechnologies, Inc., has reported changes in his beneficial ownership of the company's stock.
• On March 26, 2025, Leonard purchased 20,407 shares of common stock at a weighted average price of $5.0395 per share.
• On March 27, 2025, he purchased an additional 16,593 shares at a weighted average price of $5.1883 per share.
• Following these transactions, Leonard directly owns 141,800 shares of Adverum Biotechnologies, Inc.
• Leonard also has indirect ownership of 2,722,761 shares through his role as managing member of BML Capital Management, LLC, which serves as the general partner of BML Investment Partners, L.P.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to insider buying, which often signals confidence in the company's future. However, it's important to consider the size of the purchases relative to the director's existing holdings and the overall market capitalization of the company.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often viewed as a positive sign for a company, suggesting that those with the most knowledge of the company's prospects are optimistic about its future.

Stakeholder Impact

• Shareholders may view the director's stock purchases as a positive signal, potentially leading to increased investor confidence.

Key Dates

Keywords

Adverum Biotechnologies, ADVM, insider trading, beneficial ownership, stock purchase, director, Leonard, BML Investment Partners